Consultant dermatologists Dr Firas Al-Niaimi and Dr Faisal R. Ali share their views on how the coronavirus will impact cosmetic dermatology
Insurance provider Hamilton Fraser Cosmetic Insurance is undertaking a survey to understand the impact of COVID-19 on medical aesthetic practitioners and to share best practice advice.
The American College of Surgeons (ACS) has released a new surgical resource document titled ‘Local Resumption of Elective Surgery Guidance’, as a guide for facilities that are preparing to resume elective surgery once COVID-19 has peaked in their respective areas.
Aesthetic practitioners Dr Martyn King and Sharon King are in the process of launching a national COVID-19 antibody testing service for the general public in collaboration with CST Pharma.
The Joint Council for Cosmetic Practitioners (JCCP) has published guidance on returning to work in aesthetic clinics.
The British College of Aesthetic Medicine (BCAM) has sent its members guidance on reopening their clinics based on the legal opinion of a QC working in public law.
The British Association of Cosmetic Nurses (BACN) has published Suggested Operational Guidelines for COVID-19 – Reintegration of Medical Aesthetic Services for its members.
New guidance has been published in the US to prepare aesthetic medical practitioners and their staff to safely return to work.
Research conducted by Hamilton Fraser Cosmetic Insurance has indicated that 44% of aesthetic practitioners have returned to the NHS during the COVID-19 pandemic.
The Consortium of Aesthetic Plastic Surgery Clinic Owners (CAPSCO) has produced a document that provides consensus on appropriate infection control and advice on reopening plastic surgery clinics in the coming weeks.